Patents Represented by Attorney, Agent or Law Firm Kilyk & Bowersoy, P.L.L.C.
  • Patent number: 6818624
    Abstract: A therapeutic agent for a cancer comprising a therapeutically effective amount of an active ingredient, wherein the therapeutic agent is used referring to an ability of acting on NK cell antigen receptor NKR-P1 of NKT cell as an index of the ability to activate the NKT cell.
    Type: Grant
    Filed: July 3, 2002
    Date of Patent: November 16, 2004
    Assignee: Orient Cancer Therapy Co., Ltd.
    Inventor: Akikuni Yagita